Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Gallstones: new insights into an old story.

Tiderington E, Lee SP, Ko CW.

F1000Res. 2016 Jul 26;5. pii: F1000 Faculty Rev-1817. doi: 10.12688/f1000research.8874.1. eCollection 2016 Jul 26. Review.

2.

Risk factors for requiring cholecystectomy for gallstone disease in a prospective population-based cohort study.

Talseth A, Ness-Jensen E, Edna TH, Hveem K.

Br J Surg. 2016 Sep;103(10):1350-7. doi: 10.1002/bjs.10205. Epub 2016 May 25.

3.

Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease.

Colak Y, Bozbey G, Erim T, Caklili OT, Ulasoglu C, Senates E, Mutlu HH, Mesci B, Do─čan MS, Tasan G, Enc FY, Tuncer I.

J Neurogastroenterol Motil. 2016 Jul 30;22(3):470-6. doi: 10.5056/jnm15159.

4.

Clinical Relationship between Steatocholecystitis and Gallbladder Contractility Measured by Cholescintigraphy.

Bang CS, Lee YS, Yoon JH, Kim YJ, Kim JB, Kim DJ.

Gastroenterol Res Pract. 2015;2015:730930. doi: 10.1155/2015/730930. Epub 2015 Jan 29.

5.

Gastrointestinal morbidity in obesity.

Acosta A, Camilleri M.

Ann N Y Acad Sci. 2014 Apr;1311:42-56. doi: 10.1111/nyas.12385. Epub 2014 Mar 6. Review.

6.

Changes in demographic features of gallstone disease: 30 years of surgically treated patients.

Chang YR, Jang JY, Kwon W, Park JW, Kang MJ, Ryu JK, Kim YT, Yun YB, Kim SW.

Gut Liver. 2013 Nov;7(6):719-24. doi: 10.5009/gnl.2013.7.6.719. Epub 2013 Jun 11.

7.

Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort.

Racine A, Bijon A, Fournier A, Mesrine S, Clavel-Chapelon F, Carbonnel F, Boutron-Ruault MC.

CMAJ. 2013 Apr 16;185(7):555-61. doi: 10.1503/cmaj.121490. Epub 2013 Mar 18.

8.

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

Fracanzani AL, Valenti L, Russello M, Miele L, Bertelli C, Bellia A, Masetti C, Cefalo C, Grieco A, Marchesini G, Fargion S.

PLoS One. 2012;7(7):e41183. doi: 10.1371/journal.pone.0041183. Epub 2012 Jul 25.

9.

Pediatric obesity and gallstone disease.

Koebnick C, Smith N, Black MH, Porter AH, Richie BA, Hudson S, Gililland D, Jacobsen SJ, Longstreth GF.

J Pediatr Gastroenterol Nutr. 2012 Sep;55(3):328-33. doi: 10.1097/MPG.0b013e31824d256f.

10.

Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women.

Kim SS, Lee JG, Kim DW, Kim BH, Jeon YK, Kim MR, Huh JE, Mok JY, Kim SJ, Kim YK, Kim IJ.

Korean J Intern Med. 2011 Sep;26(3):285-93. doi: 10.3904/kjim.2011.26.3.285. Epub 2011 Sep 13.

11.

Gastrointestinal issues in the assessment and management of the obese patient.

Hussain Z, Quigley EM.

Gastroenterol Hepatol (N Y). 2007 Jul;3(7):559-69.

12.

The Individualized Target HbA1c: A New Method for Improving Macrovascular Risk and Glycemia Without Hypoglycemia and Weight Gain.

Eldor R, Raz I.

Rev Diabet Stud. 2009 Spring;6(1):6-12. doi: 10.1900/RDS.2009.6.6. Epub 2009 May 10.

13.

Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study.

Shen W, Punyanitya M, Silva AM, Chen J, Gallagher D, Sardinha LB, Allison DB, Heymsfield SB.

Nutr Metab (Lond). 2009 Apr 16;6:17. doi: 10.1186/1743-7075-6-17.

Supplemental Content

Support Center